Explore by topic
Follow the evidence, not the hype.
Use these topic guides to move from broad questions to relevant evidence, safety context and primary-source reporting.
A growing library
Each hub connects related explainers and will expand as new evidence, regulatory decisions and expert reviews are published.
Psilocybin
A structured route through psilocybin research, depression trials, microdosing claims, safety screening and UK legal context.
MDMA
Evidence, approval status, therapy protocols, safeguarding and trial-design questions surrounding MDMA-assisted approaches.
Ketamine
How ketamine differs from classic psychedelics—and what to examine when assessing treatment, safety and clinic claims.
Safety & Ethics
Screening, contraindications, professional boundaries, informed consent and the systems needed to protect participants and patients.
Clinical Trials
Learn how psychedelic trials use controls, blinding, outcome measures, selected populations and follow-up—and where bias can enter.
UK Law & Regulation
A plain-English route through controlled-drug scheduling, research access, treatment claims and provider regulation in the UK.
